Added to YB: 2025-12-09
Pitch date: 2025-12-05
STAA [neutral]
STAAR Surgical Company
-5.52%
current return
Author Info
Company Info
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.
Market Cap
$1.3B
Pitch Price
$25.54
Price Target
N/A
Dividend
N/A
EV/EBITDA
-25.09
P/E
-13.52
EV/Sales
5.02
Sector
Health Care Equipment and Supplies
Category
special_situation
Weird Events, Part 1: Alcon’s STAAR Surgical Deal ($ALC, $STAA)
STAA (quick overview): Alcon's $28/share bid (60% premium but down from $50 early 2024 & rejected $58 April offer) faces shareholder revolt led by Broadwood (30% stake). China sales crashed but rebounding. Shareholders forced deal delays, secured go-shop w/ no break fee. Broadwood planning special meeting to oust directors & kill deal. 5 event angles: merger arb + activism + go-shop + contested vote + proxy fight.
Read full article (3 min)